Carvedilol AURUS

Carvedilol AURUS may be available in the countries listed below.

Ingredient matches for Carvedilol AURUS

Carvedilol

Carvedilol is reported as an ingredient of Carvedilol AURUS in the following countries:

• Germany

International Drug Name Search

Ofloxacine ratiopharm

Ofloxacine ratiopharm may be available in the countries listed below.

Ingredient matches for Ofloxacine ratiopharm

Ofloxacin

Ofloxacin is reported as an ingredient of Ofloxacine ratiopharm in the following countries:

• Belgium


• France


• Netherlands

International Drug Name Search

Diamsalina

Diamsalina may be available in the countries listed below.

Ingredient matches for Diamsalina

Dicloxacillin

Dicloxacillin sodium salt (a derivative of Dicloxacillin) is reported as an ingredient of Diamsalina in the following countries:

• Mexico

International Drug Name Search

Alpurase

Alpurase may be available in the countries listed below.

Ingredient matches for Alpurase

Allopurinol

Allopurinol is reported as an ingredient of Alpurase in the following countries:

• Philippines

International Drug Name Search

MetroGel

See also: Generic MetroCream, Generic MetroGel-Vaginal, Generic MetroLotion

MetroGel is a brand name of metronidazole topical, approved by the FDA in the following formulation(s):

METROGEL (metronidazole - gel; topical)

• 
  Manufacturer: GALDERMA LABS LP
  
  Approval date: November 22, 1988
  
  Strength(s): 0.75% ^[RLD][AB]


• 
  Manufacturer: GALDERMA LABS LP
  
  Approval date: June 30, 2005
  
  Strength(s): 1% ^[RLD][AB]

Has a generic version of MetroGel been approved?

A generic version of MetroGel has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to MetroGel and have been approved by the FDA:

metronidazole gel; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: June 6, 2006
  
  Strength(s): 0.75% ^[AB]


• 
  Manufacturer: G AND W LABS INC
  
  Approval date: January 19, 2011
  
  Strength(s): 0.75% ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: July 18, 2006
  
  Strength(s): 0.75% ^[AB]


• 
  Manufacturer: TOLMAR
  
  Approval date: July 13, 2006
  
  Strength(s): 0.75% ^[AB]


• 
  Manufacturer: TOLMAR
  
  Approval date: July 22, 2011
  
  Strength(s): 1% ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of MetroGel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Aqueous compositions containing metronidazole
  Patent 6,881,726
  Issued: April 19, 2005
  Inventor(s): Chang; Yunik & Dow; Gordon J.
  Assignee(s): Dow Pharmaceutical Sciences
  An aqueous solution of metronidazole in which the concentration of metronidazole is higher than 0.75%. The solution contains a combination of solubility-enhancing agents, one of which is a cyclodextrin such as beta-cyclodextrin and the second is a compound other than a cyclodextrin. Methods of manufacture and therapeutic use of the solution are disclosed.
  
  Patent expiration dates:
  
  
  • February 21, 2022
    
    ✓ 
    Patent use: ONCE A DAY TOPICAL TREATMENT OF THE INFLAMMATORY LESIONS OF ROSACEA
    ✓ 
    Drug product
  
  



• 
  Aqueous compositions containing metronidazole
  Patent 7,348,317
  Issued: March 25, 2008
  Inventor(s): Chang; Yunik & Dow; Gordon J.
  Assignee(s): Dow Pharmaceutical Sciences
  An aqueous solution of metronidazole in which the concentration of metronidazole is higher than 0.75%. The solution contains a combination of solubility-enhancing agents, one of which is a cyclodextrin such as beta-cyclodextrin and the second is niacin or niacinamide. Methods of manufacture and therapeutic use of the solution are disclosed.
  
  Patent expiration dates:
  
  
  • February 21, 2022
    
    ✓ 
    Patent use: ONCE A DAY TOPICAL TREATMENT OF THE INFLAMMATORY LESIONS OF ROSACEA
    ✓ 
    Drug product
  
  

See also...

• MetroGel Cream Consumer Information (Wolters Kluwer)
• MetroGel Gel Consumer Information (Wolters Kluwer)
• MetroGel Consumer Information (Cerner Multum)
• Metrogel Topical Advanced Consumer Information (Micromedex)
• Metronidazole Cream Consumer Information (Wolters Kluwer)
• Metronidazole Emulsion Consumer Information (Wolters Kluwer)
• Metronidazole Gel Consumer Information (Wolters Kluwer)
• Metronidazole topical Consumer Information (Cerner Multum)
• Metronidazole vaginal Consumer Information (Cerner Multum)
• Flagyl Vaginal Advanced Consumer Information (Micromedex)
• Neo-Metric Advanced Consumer Information (Micromedex)
• Nidagel Advanced Consumer Information (Micromedex)
• Metronidazole Topical Advanced Consumer Information (Micromedex)
• Metronidazole Vaginal Advanced Consumer Information (Micromedex)
• Metronidazole topical AHFS DI Monographs (ASHP)

Claritromicina Edigen

Claritromicina Edigen may be available in the countries listed below.

Ingredient matches for Claritromicina Edigen

Clarithromycin

Clarithromycin is reported as an ingredient of Claritromicina Edigen in the following countries:

• Spain

International Drug Name Search

Quick-Pep

Ingredient matches for Quick-Pep

Caffeine

Caffeine is reported as an ingredient of Quick-Pep in the following countries:

• United States

International Drug Name Search

Corsim

Corsim may be available in the countries listed below.

Ingredient matches for Corsim

Simvastatin

Simvastatin is reported as an ingredient of Corsim in the following countries:

• Czech Republic

International Drug Name Search

Depam

Depam may be available in the countries listed below.

Ingredient matches for Depam

Domperidone

Domperidone is reported as an ingredient of Depam in the following countries:

• India

Pantoprazole

Pantoprazole is reported as an ingredient of Depam in the following countries:

• India

International Drug Name Search

Flexure

Flexure may be available in the countries listed below.

Ingredient matches for Flexure

Chondroitin Polysulfate

Chondroitin Polysulfate is reported as an ingredient of Flexure in the following countries:

• Peru

Glucosamine

Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Flexure in the following countries:

• Peru

International Drug Name Search

Morphasol

Morphasol may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Morphasol

Butorphanol

Butorphanol tartrate (a derivative of Butorphanol) is reported as an ingredient of Morphasol in the following countries:

• Switzerland

International Drug Name Search

Coopers Ectoforce Sheep Dip

Coopers Ectoforce Sheep Dip may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Coopers Ectoforce Sheep Dip

Dimpylate

Dimpylate is reported as an ingredient of Coopers Ectoforce Sheep Dip in the following countries:

• United Kingdom

International Drug Name Search

Diltiazem 24-Hour Sustained-Release Capsules

Pronunciation: dil-TYE-a-zem
Generic Name: Diltiazem
Brand Name: Examples include Diltia XT and Dilt-XR

Diltiazem 24-Hour Sustained-Release Capsules are used for:

Treating high blood pressure and chronic stable angina (chest pain). It may be used alone or in combination with other medicines. It may also be used for other conditions as determined by your doctor.

Diltiazem 24-Hour Sustained-Release Capsules are a calcium channel blocker. It works by relaxing (dilating) your blood vessels, lowering blood pressure, and decreasing heart rate, which lowers the workload of the heart. It also dilates coronary arteries, which increases blood flow to the heart.

Do NOT use Diltiazem 24-Hour Sustained-Release Capsules if:

• you are allergic to any ingredient in Diltiazem 24-Hour Sustained-Release Capsules


• you have certain heart problems (eg, sick sinus syndrome, second- or third-degree heart block) and do not have a pacemaker, you have very low blood pressure, or you have fluid buildup in the lungs during or soon after a heart attack


• you are taking erythromycin

Contact your doctor or health care provider right away if any of these apply to you.

Before using Diltiazem 24-Hour Sustained-Release Capsules:

Some medical conditions may interact with Diltiazem 24-Hour Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have heart failure, a recent heart attack with lung congestion, heart block, a very slow heart rate, or other heart problems; low blood pressure; certain stomach or intestine problems (eg, narrowing); liver disease; or kidney problems


• if you are taking other medicines for high blood pressure or heart conditions

Some MEDICINES MAY INTERACT with Diltiazem 24-Hour Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Antiarrhythmics (eg, amiodarone, dronedarone), cimetidine, clonidine, HIV protease inhibitors (eg, atazanavir, indinavir), or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Diltiazem 24-Hour Sustained-Release Capsules's side effects, such as heart rhythm problems


• Benzodiazepines (eg, alprazolam), beta-blockers (eg, propranolol), buspirone, carbamazepine, cilostazol, cisapride, colchicine, corticosteroids (eg, hydrocortisone), cyclosporine, digoxin, everolimus, fentanyl, HMG-CoA reductase inhibitors (eg, simvastatin), hydantoins (eg, phenytoin), lurasidone, macrolide antibiotics (eg, erythromycin ), macrolide immunosuppressants (eg, tacrolimus), nifedipine, quinidine, ranolazine, theophylline, or vasopressin antagonists (eg, tolvaptan) because the risk of their side effects, some potentially life-threatening, may be increased by Diltiazem 24-Hour Sustained-Release Capsules


• Moricizine or rifamycins (eg, rifampin) because they may decrease Diltiazem 24-Hour Sustained-Release Capsules's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Diltiazem 24-Hour Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Diltiazem 24-Hour Sustained-Release Capsules:

Use Diltiazem 24-Hour Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Diltiazem 24-Hour Sustained-Release Capsules by mouth on an empty stomach at least 1 hour before or 2 hours after eating.


• Swallow Diltiazem 24-Hour Sustained-Release Capsules whole. Do not open, break, crush, or chew before swallowing.


• Taking Diltiazem 24-Hour Sustained-Release Capsules at the same time each day will help you remember to take it.


• Continue to take Diltiazem 24-Hour Sustained-Release Capsules even if you feel well. Do not miss any doses.


• If you miss a dose of Diltiazem 24-Hour Sustained-Release Capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Diltiazem 24-Hour Sustained-Release Capsules.

Important safety information:

• Diltiazem 24-Hour Sustained-Release Capsules may cause dizziness, lightheadedness, or drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use Diltiazem 24-Hour Sustained-Release Capsules with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Diltiazem 24-Hour Sustained-Release Capsules may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Diltiazem 24-Hour Sustained-Release Capsules may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Diltiazem 24-Hour Sustained-Release Capsules. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Patients who take medicine for high blood pressure often feel tired or run down for a few weeks after starting treatment. Be sure to take your medicine even if you may not feel "normal." Tell your doctor if you develop any new symptoms.


• Do not suddenly stop taking Diltiazem 24-Hour Sustained-Release Capsules. Your condition may get worse if you suddenly stop taking it. If you need to stop Diltiazem 24-Hour Sustained-Release Capsules or add a new medicine, your doctor will gradually lower your dose.


• Tell your doctor or dentist that you take Diltiazem 24-Hour Sustained-Release Capsules before you receive any medical or dental care, emergency care, or surgery.


• Be sure to have your blood pressure checked regularly while taking Diltiazem 24-Hour Sustained-Release Capsules.


• Lab tests, including blood pressure, electrocardiogram (ECG), and heart rate, may be performed while you use Diltiazem 24-Hour Sustained-Release Capsules. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Diltiazem 24-Hour Sustained-Release Capsules with caution in the ELDERLY; they may be more sensitive to its effects, especially swelling of the ankles, feet, or hands; dizziness; and slow heartbeat.


• Diltiazem 24-Hour Sustained-Release Capsules should be used with extreme caution in CHILDREN; safety and effectiveness have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Diltiazem 24-Hour Sustained-Release Capsules while you are pregnant. Diltiazem 24-Hour Sustained-Release Capsules are found in breast milk. Do not breast-feed while taking Diltiazem 24-Hour Sustained-Release Capsules.

Possible side effects of Diltiazem 24-Hour Sustained-Release Capsules:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; dizziness; facial flushing; headache; lightheadedness; tiredness; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); chest pain; fainting; fast, slow, or irregular heartbeat; fever, chills, or sore throat; hallucinations; mental or mood changes; personality changes; reddened, blistered, or swollen skin; severe or persistent dizziness, lightheadedness, nausea, or vomiting; shortness of breath; sudden weight gain; swelling of the feet, ankles, or hands; symptoms of liver problems (eg, dark urine, pale stools, yellowing of the skin or eyes); tender, bleeding, or swollen gums; unusual bleeding or bruising; unusual or persistent tiredness or weakness; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Diltiazem side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; difficulty breathing, especially when lying down; dizziness; drowsiness; fainting; lightheadedness, especially when standing; loss of consciousness; nausea; nervousness; slurred speech; unusual weakness; very slow heart rate.

Proper storage of Diltiazem 24-Hour Sustained-Release Capsules:

Store Diltiazem 24-Hour Sustained-Release Capsules at room temperature, between 59 and 77 degrees F (15 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Diltiazem 24-Hour Sustained-Release Capsules out of the reach of children and away from pets.

General information:

• If you have any questions about Diltiazem 24-Hour Sustained-Release Capsules, please talk with your doctor, pharmacist, or other health care provider.


• Diltiazem 24-Hour Sustained-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Diltiazem 24-Hour Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Diltiazem resources

• Diltiazem Side Effects (in more detail)
• Diltiazem Use in Pregnancy & Breastfeeding
• Drug Images
• Diltiazem Drug Interactions
• Diltiazem Support Group
• 31 Reviews for Diltiazem - Add your own review/rating

Compare Diltiazem with other medications

• Angina Pectoris Prophylaxis
• Atrial Fibrillation
• Atrial Flutter
• Heart Failure
• High Blood Pressure
• Raynaud's Syndrome
• Supraventricular Tachycardia